Cas:157915-07-6 8-Nitroquinoline-6-carboxylic acid manufacturer & supplier

We serve Chemical Name:8-Nitroquinoline-6-carboxylic acid CAS:157915-07-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

8-Nitroquinoline-6-carboxylic acid

Chemical Name:8-Nitroquinoline-6-carboxylic acid
CAS.NO:157915-07-6
Synonyms:8-nitro-6-quinolinecarboxylic acid
Molecular Formula:C10H6N2O4
Molecular Weight:218.16600
HS Code:2933499090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:414.8ºC at 760 mmHg
Density:1.545g/cm3
Index of Refraction:1.718
PSA:96.01000
Exact Mass:218.03300
LogP:2.36440

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 8-nitro-6-quinolinecarboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,8-nitro-6-quinolinecarboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,8-nitro-6-quinolinecarboxylic acid Use and application,8-nitro-6-quinolinecarboxylic acid technical grade,usp/ep/jp grade.


Related News: According to the business type, it can be divided into non-CMO business of APIs and intermediates and CMO business of APIs and intermediates. 8-Nitroquinoline-6-carboxylic acid manufacturer Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country. 8-Nitroquinoline-6-carboxylic acid supplier We manufacture APIs and drug manufacturers make medicines from APIs. 8-Nitroquinoline-6-carboxylic acid vendor Mankind Pharmaceuticals on Monday said it has inked a licensing pact with Glenmark Pharmaceuticals to co-market diabetes drug Remogliflozin Etabonate in the country. 8-Nitroquinoline-6-carboxylic acid factory According to the business type, it can be divided into non-CMO business of APIs and intermediates and CMO business of APIs and intermediates.